Stakeholders on both sides of the proposed payment demonstration for Medicare Part B drugs appear to have made efforts to organize comments to the Centers for Medicare and Medicaid Services, with opponents constituting the overwhelming majority of the stakeholder submissions.
Part B Demo Comments Overwhelmingly Negative, Uniform In Content
More than 90% of comments submitted on proposed Medicare payment experiment for Part B drugs were negative, and most were submitted by patients and health care providers.